US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 1.8400
  • -0.0050-0.27%
Close Dec 20 16:00 ET
  • 1.8487
  • +0.0087+0.47%
Post 19:59 ET
66.42MMarket Cap-0.42P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.73%-27.44M
12.70%-28.21M
21.56%-28.76M
42.48%-124.37M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
-0.23%-216.22M
4.09%-36.34M
Net income from continuing operations
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
7.85%-279.82M
49.07%-54.46M
Operating gains losses
242.40%262.15K
-71.87%357.61K
-61.87%817.19K
-51.68%4.35M
-70.55%1.12M
-114.73%-184.1K
35.76%1.27M
-28.89%2.14M
806.47%9M
3,586.77%3.8M
Depreciation and amortization
-25.84%765.86K
-27.53%828.63K
-34.06%759.73K
-36.25%3.5M
-87.01%175.23K
-24.16%1.03M
-18.91%1.14M
-16.25%1.15M
16.18%5.5M
-2.23%1.35M
Deferred tax
----
----
----
---32.05K
----
----
----
----
--0
----
Other non cash items
--0
--0
-61.66%-355.65K
-16.67%155.81K
-9.94%282.33K
0.00%-220K
0.00%313.49K
0.00%-220K
-78.22%186.98K
-34.73%313.49K
Change In working capital
61.26%-2.86M
179.17%1.78M
-157.61%-851.25K
-151.73%-10.26M
-116.35%-2.11M
79.85%-7.38M
-105.19%-2.24M
329.31%1.48M
-60.61%19.83M
-78.14%12.91M
-Change in receivables
-103.00%-89.07K
1,058.35%777.42K
-102.18%-145.85K
351.82%9.33M
84.25%-261.03K
130.24%2.97M
97.91%-81.12K
1,138.45%6.7M
-133.60%-3.71M
-82.76%-1.66M
-Change in prepaid assets
139.27%748.74K
-199.01%-1.85M
-95.18%1.9M
831.20%39.02M
-101.92%-264.56K
-22.57%-1.91M
107.57%1.87M
455.75%39.32M
15.88%-5.34M
-70.13%13.81M
-Change in payables and accrued expense
62.00%-2.98M
215.27%3.28M
94.50%-2.5M
-264.92%-54.22M
-16.06%2.01M
71.36%-7.85M
-104.35%-2.84M
-507.22%-45.54M
23.98%32.87M
-84.65%2.39M
-Change in other current assets
-68.33%19.5K
234.98%19.4K
--0
-89.39%78.73K
--0
-9.66%61.58K
-102.85%-14.37K
-79.26%31.53K
-96.98%741.75K
-94.55%17.94K
-Change in other current liabilities
-127.58%-21.92K
--0
-105.31%-87.49K
-19.71%-2.45M
-281.76%-3.72M
-88.14%79.46K
81.16%-462.38K
132.57%1.65M
32.05%-2.05M
34.44%-974.1K
-Change in other working capital
27.83%-534.87K
37.31%-446.59K
98.30%-11.79K
24.87%-2.02M
118.73%126.2K
92.36%-741.11K
-108.57%-712.38K
-9.31%-693.69K
-13.54%-2.69M
-1.14%-673.69K
Cash from discontinued investing activities
Operating cash flow
5.73%-27.44M
12.70%-28.21M
21.56%-28.76M
42.48%-124.37M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
-0.23%-216.22M
4.09%-36.34M
Investing cash flow
Cash flow from continuing investing activities
356.25%14.08M
-81.51%9.97M
138.86%45.38M
-20.29%87.36M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19M
162.50%109.59M
931.55%54M
Net PPE purchase and sale
--0
-1,791.09%-452.25K
-100.62%-35.58K
708.61%5.9M
189.80%148.26K
--0
96.67%-23.92K
--5.77M
21.27%-969.15K
74.35%-165.11K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---2M
--0
Net investment purchase and sale
356.25%14.08M
-80.68%10.42M
243.40%45.42M
-27.63%81.46M
-63.45%19.8M
-112.31%-5.49M
662.55%53.93M
-43.32%13.23M
164.64%112.56M
1,025.86%54.17M
Cash from discontinued investing activities
Investing cash flow
356.25%14.08M
-81.51%9.97M
138.86%45.38M
-20.29%87.36M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19M
162.50%109.59M
931.55%54M
Financing cash flow
Cash flow from continuing financing activities
-5.44%660.65K
1,045.85%33.03M
-2,575.77%-11.36M
-93.90%5M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.7K
-61.30%81.84M
-85.99%6.67M
Net issuance payments of debt
--0
--0
---16.42M
----
----
--0
--0
--0
----
----
Net common stock issuance
-5.82%667.07K
485.20%17.06M
--5.23M
-93.42%5.46M
-72.43%1.84M
-81.19%708.28K
-93.25%2.92M
--0
-60.39%82.96M
-85.91%6.67M
Proceeds from stock option exercised by employees
--16.15M
----
----
--0
--0
--0
----
----
-95.76%283.02K
--0
Net other financing activities
-167,286.68%-16.15M
49,357.61%15.91M
58.97%-174.25K
66.61%-466.65K
--0
79.85%-9.65K
90.01%-32.29K
58.62%-424.7K
69.69%-1.4M
--0
Cash from discontinued financing activities
Financing cash flow
-5.44%660.65K
1,045.85%33.03M
-2,575.77%-11.36M
-93.90%5M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.7K
-61.30%81.84M
-85.99%6.67M
Net cash flow
Beginning cash position
-34.75%34.39M
-30.58%19.6M
-69.11%14.31M
-34.88%46.33M
-14.48%18.8M
28.25%52.71M
-52.15%28.24M
-34.88%46.33M
-71.63%71.14M
-67.64%21.99M
Current changes in cash
62.53%-12.7M
-39.57%14.79M
129.07%5.26M
-29.15%-32.01M
-118.47%-4.49M
-77.54%-33.91M
236.79%24.47M
-49.16%-18.09M
86.19%-24.79M
657.96%24.33M
Effect of exchange rate changes
--0
--0
1,789.42%32.4K
84.66%-3.92K
-96.09%483
87.27%-2.11K
97.46%-376
70.74%-1.92K
15.19%-25.56K
268.65%12.35K
End cash Position
15.33%21.69M
-34.75%34.39M
-30.58%19.6M
-69.11%14.31M
-69.11%14.31M
-14.48%18.8M
28.25%52.71M
-52.15%28.24M
-34.88%46.33M
-34.88%46.33M
Free cash flow
5.73%-27.44M
11.37%-28.66M
22.09%-28.8M
42.59%-124.69M
28.02%-26.28M
56.91%-29.11M
36.89%-32.34M
40.27%-36.96M
-0.11%-217.18M
5.27%-36.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.73%-27.44M12.70%-28.21M21.56%-28.76M42.48%-124.37M27.69%-26.28M56.85%-29.11M36.05%-32.31M40.75%-36.66M-0.23%-216.22M4.09%-36.34M
Net income from continuing operations 25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M7.85%-279.82M49.07%-54.46M
Operating gains losses 242.40%262.15K-71.87%357.61K-61.87%817.19K-51.68%4.35M-70.55%1.12M-114.73%-184.1K35.76%1.27M-28.89%2.14M806.47%9M3,586.77%3.8M
Depreciation and amortization -25.84%765.86K-27.53%828.63K-34.06%759.73K-36.25%3.5M-87.01%175.23K-24.16%1.03M-18.91%1.14M-16.25%1.15M16.18%5.5M-2.23%1.35M
Deferred tax ---------------32.05K------------------0----
Other non cash items --0--0-61.66%-355.65K-16.67%155.81K-9.94%282.33K0.00%-220K0.00%313.49K0.00%-220K-78.22%186.98K-34.73%313.49K
Change In working capital 61.26%-2.86M179.17%1.78M-157.61%-851.25K-151.73%-10.26M-116.35%-2.11M79.85%-7.38M-105.19%-2.24M329.31%1.48M-60.61%19.83M-78.14%12.91M
-Change in receivables -103.00%-89.07K1,058.35%777.42K-102.18%-145.85K351.82%9.33M84.25%-261.03K130.24%2.97M97.91%-81.12K1,138.45%6.7M-133.60%-3.71M-82.76%-1.66M
-Change in prepaid assets 139.27%748.74K-199.01%-1.85M-95.18%1.9M831.20%39.02M-101.92%-264.56K-22.57%-1.91M107.57%1.87M455.75%39.32M15.88%-5.34M-70.13%13.81M
-Change in payables and accrued expense 62.00%-2.98M215.27%3.28M94.50%-2.5M-264.92%-54.22M-16.06%2.01M71.36%-7.85M-104.35%-2.84M-507.22%-45.54M23.98%32.87M-84.65%2.39M
-Change in other current assets -68.33%19.5K234.98%19.4K--0-89.39%78.73K--0-9.66%61.58K-102.85%-14.37K-79.26%31.53K-96.98%741.75K-94.55%17.94K
-Change in other current liabilities -127.58%-21.92K--0-105.31%-87.49K-19.71%-2.45M-281.76%-3.72M-88.14%79.46K81.16%-462.38K132.57%1.65M32.05%-2.05M34.44%-974.1K
-Change in other working capital 27.83%-534.87K37.31%-446.59K98.30%-11.79K24.87%-2.02M118.73%126.2K92.36%-741.11K-108.57%-712.38K-9.31%-693.69K-13.54%-2.69M-1.14%-673.69K
Cash from discontinued investing activities
Operating cash flow 5.73%-27.44M12.70%-28.21M21.56%-28.76M42.48%-124.37M27.69%-26.28M56.85%-29.11M36.05%-32.31M40.75%-36.66M-0.23%-216.22M4.09%-36.34M
Investing cash flow
Cash flow from continuing investing activities 356.25%14.08M-81.51%9.97M138.86%45.38M-20.29%87.36M-63.07%19.94M-112.33%-5.49M623.16%53.91M-10.93%19M162.50%109.59M931.55%54M
Net PPE purchase and sale --0-1,791.09%-452.25K-100.62%-35.58K708.61%5.9M189.80%148.26K--096.67%-23.92K--5.77M21.27%-969.15K74.35%-165.11K
Net business purchase and sale --------------0-------------------2M--0
Net investment purchase and sale 356.25%14.08M-80.68%10.42M243.40%45.42M-27.63%81.46M-63.45%19.8M-112.31%-5.49M662.55%53.93M-43.32%13.23M164.64%112.56M1,025.86%54.17M
Cash from discontinued investing activities
Investing cash flow 356.25%14.08M-81.51%9.97M138.86%45.38M-20.29%87.36M-63.07%19.94M-112.33%-5.49M623.16%53.91M-10.93%19M162.50%109.59M931.55%54M
Financing cash flow
Cash flow from continuing financing activities -5.44%660.65K1,045.85%33.03M-2,575.77%-11.36M-93.90%5M-72.43%1.84M-81.67%698.63K-93.29%2.88M-101.49%-424.7K-61.30%81.84M-85.99%6.67M
Net issuance payments of debt --0--0---16.42M----------0--0--0--------
Net common stock issuance -5.82%667.07K485.20%17.06M--5.23M-93.42%5.46M-72.43%1.84M-81.19%708.28K-93.25%2.92M--0-60.39%82.96M-85.91%6.67M
Proceeds from stock option exercised by employees --16.15M----------0--0--0---------95.76%283.02K--0
Net other financing activities -167,286.68%-16.15M49,357.61%15.91M58.97%-174.25K66.61%-466.65K--079.85%-9.65K90.01%-32.29K58.62%-424.7K69.69%-1.4M--0
Cash from discontinued financing activities
Financing cash flow -5.44%660.65K1,045.85%33.03M-2,575.77%-11.36M-93.90%5M-72.43%1.84M-81.67%698.63K-93.29%2.88M-101.49%-424.7K-61.30%81.84M-85.99%6.67M
Net cash flow
Beginning cash position -34.75%34.39M-30.58%19.6M-69.11%14.31M-34.88%46.33M-14.48%18.8M28.25%52.71M-52.15%28.24M-34.88%46.33M-71.63%71.14M-67.64%21.99M
Current changes in cash 62.53%-12.7M-39.57%14.79M129.07%5.26M-29.15%-32.01M-118.47%-4.49M-77.54%-33.91M236.79%24.47M-49.16%-18.09M86.19%-24.79M657.96%24.33M
Effect of exchange rate changes --0--01,789.42%32.4K84.66%-3.92K-96.09%48387.27%-2.11K97.46%-37670.74%-1.92K15.19%-25.56K268.65%12.35K
End cash Position 15.33%21.69M-34.75%34.39M-30.58%19.6M-69.11%14.31M-69.11%14.31M-14.48%18.8M28.25%52.71M-52.15%28.24M-34.88%46.33M-34.88%46.33M
Free cash flow 5.73%-27.44M11.37%-28.66M22.09%-28.8M42.59%-124.69M28.02%-26.28M56.91%-29.11M36.89%-32.34M40.27%-36.96M-0.11%-217.18M5.27%-36.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+1.25%